Purchase Order 75A50122P00008
- Not listed
- This federal contract award to OraSure Technologies Inc. by the Biomedical Advanced Research and Development Authority (BARDA), an agency within the U.S. Department of Health and Human Services (HHS), is for the procurement of point-of-care diagnostic tests to detect the Ebola virus in cadavers. The purpose is to acquire handheld, lateral flow, rapid antigen tests that are either FDA Emergency Use Authorized or 510(k) cleared, and able to sample oral fluid from cadavers of individuals...
- This federal contract award to Orasure Technologies Inc. (Orasure) is for the procurement of OraQuick Ebola Rapid Antigen Tests by the Centers for Disease Control and Prevention (CDC). The definitive contract, valued at $278,620.89, was awarded on August 1, 2016 with a completion date of November 30, 2016. This contract does not have a set-aside designation, indicating it was awarded through full and open competition. Orasure is a global manufacturer of oral fluid diagnostic products and...
- This is a federal contract award to Orasure Technologies Inc., a for-profit manufacturer of diagnostic medical testing products, to modify the OraQuick test platform to enable antigen detection of the Ebola Zaire virus for use with various sample types. The purpose of this $11,937,826.99 cost-plus-fixed-fee contract modification is to transfer all government property associated with the original contract to a new contract. The contract is funded by the Office of the Assistant Secretary for...
- The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, awarded a $5,746,950.00 firm-fixed-price definitive contract to Orasure Technologies Inc. for the delivery of over-the-counter (OTC) COVID-19 tests. The contract has a performance period through March 19, 2025 and was not set aside for any special business designation. Orasure, a manufacturer of diagnostic products including rapid tests for HIV, Ebola, and COVID-19, has been a...
- The Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response awarded a $7,048,087.00 firm fixed price contract to Orasure Technologies Inc. (doing business as Orasure) for the provision of INTELISWAB COVID-19 rapid tests. This contract was set aside exclusively for small businesses and has a period of performance through April 30, 2024. The original solicitation, issued by the Biomedical Advanced Research and Development Authority (BARDA)...
- Orasure Technologies Inc., doing business as Orasure, has been awarded a definitive contract valued at $540,609 by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. Under this firm fixed price contract, Orasure will conduct research and development of an antibody test to support the Coronavirus COVID-19 National Interest Action Code and COVID-19 - R & D OF A RAPID ANTIGEN TEST major program. Performance will take place in Fountain...
- Orasure Technologies Inc., doing business as Orasure, has been awarded a definitive contract valued at $78.1 million by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (HHS ASPR). The firm fixed price contract is for COVID 19 DIB FOR ORASURE TECHNOLOGIES COVID-19 HOME TEST INDUSTRIAL BASE EXPANSION and will support the expansion of Orasure's COVID-19 home test production capacity through March 2024. Performance will take place in...
- This definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Orasure Technologies Inc. is valued at $710,310 to support the development of a rapid antigen test for COVID-19. The contract was awarded under Special Instructions 019 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002 and will deliver research and development efforts towards a host-directed therapeutic to aid long-term outcomes from lung...
- This federal contract award, valued at $388,440,000.00, was issued by the Defense Logistics Agency Troop Support Medical to Orasure Technologies Inc., a for-profit manufacturer of diagnostic medical testing products. The contract is for the delivery of InteliSwab COVID-19 Rapid Test Kits, a type of over-the-counter COVID-19 diagnostic test. The contract has an ultimate completion date of October 6, 2022 and was awarded on October 20, 2021. No set-aside designation was used for this contract....
- The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $30.88 million definitive contract to Orasure Technologies Inc., doing business as Orasure, to provide COVID-19 home test industrial base expansion transitioning from the Department of Defense/Air Force to HHS/ASPR. The contract is for COVID-19 DIB FOR ORASURE TECHNOLOGIES COVID-19 HOME TEST INDUSTRIAL BASED EXPANSION TRANSITIONING FROM THE DOD/AF TO HHS/ASPR under Department...
The U.S. Department of Health and Human Services (HHS) awarded a $240,491.71 firm-fixed-price purchase order to OraSure Technologies Inc. (doing business as OraSure) for the acquisition of Filovirus Point-of-Care (POC) diagnostic tests. The award, which has no set-aside designation, supports the procurement of a minimum of 8,500 lateral flow, rapid antigen tests for Ebola virus that can be used on oral fluids from cadavers and have a nine-month shelf life. OraSure is the only current provider identified as capable of meeting the government's requirements. The contract includes four quantity options to purchase additional lots of the same or improved tests over the next five years. OraSure holds several significant indefinite delivery vehicles (IDVs) with federal agencies, including a $107.28 million single-award IDC with the Defense Logistics Agency Troop Support Medical for COVID-19 and other diagnostic tests, as well as a $6.38 million multiple-award IDV on the GSA Federal Supply Schedule for in-vitro diagnostic products.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Acquisition of Filovirus Point-of-Care (PoC) Diagnostic Tests | 75A50122Q00005 | Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response | Solicitation 1/1 | 1/13/22, 12:31 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Funding Only Action | ($65k) | 8/19/24 | |
| P00003 | Supplemental Agreement for work within scope | $0 | 12/22/22 | |
| P00002 | Supplemental Agreement for work within scope | $0 | 12/20/22 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 8/24/22 | |
| Not listed | Not listed | $305.6k | 2/28/22 |